Lauric Acid could be a basic Cancer Cancer Cancer Union

A review reveals how bioactive compounds in the virgin coconut oil could weaken cancer cells and can help protect the body from the harsh side effects of chemotherapy, providing hope for future natural treatment treatment options.

Study: Virgin coconut oil and its lavric acid, between anti -cancer activity and the formulation of chemotherapy toxicity: a review. Credit Picture: Santhosh Varghese/Shutterstock.com

Existing research highlights the anti -cancer effect and the mechanism of the virgin coconut oil (VCO) and lauric acid (LA). It also points out the ability of VCO to combat the harmful side effects of chemotherapy. A recent Xenobiotic newspaper The study reviewed the existing literature on the role of VCO and its bioactive union, LA, in the toxicity of cancer and chemotherapy.

VCO, LA and general health benefits

VCO is rich in bioactive compounds such as saturated fatty acids (SFAS), phospholipids, flavonoids, phenolic acids and polyphenols. These ingredients provide anti -inflammatory, antioxidant, antimicrobial and anticholisterolemic benefits, although some findings for lipids and cholesterol effects remain controversial in various studies and populations. VCO has significantly higher phenolic content than normal coconut oil, enhancing its antioxidant properties and health benefits.

LA is an important ingredient of VCO and is the most widespread medium chain fat (MCFA) in VCO. It enhances the effectiveness of anti -cancer drugs, showing preferential cytotoxicity over cancer cells in some studies, although consistent eclecticism over normal cells has not been established firmly. LA inhibits the growth of cancer cells, promotes apoptosis and inhibits the markings of cancer.

Anti -cancer effects of VCO and LA

VCO has shown a promise in the treatment of various cancers, such as lungs, chest, colon, oral and liver. Existing study emphasizes its ability to inhibit the growth of cancer cells, especially in oral and liver cancers. A VCO -based nanogenomas reinforced the effectiveness of methotremental (MTX) against lung cancer cells, while reducing the oxidative stress associated with the toxicity of chemotherapy.

Although coconut oil inhibits the growth of skin cancer cells moderately, its clinical significance is limited. LA -rich VCO has been shown to significantly inhibit the growth of colon cancer cells and supports intestinal barrier integrity. It overcame coconut oil and caused apoptosis in lung cancer and neuroblastoma cells.

Researchers have shown that VCO inhibits the proliferation of breast cancer cells and enhances the effects of treatment with trastuzumab. Computational analysis suggests that VCO affects seventeen proteins and cancer -related pathways, but further experimental validation is required. These findings are very promising, but they require more research to confirm.

There are few studies in LA. However, available data indicate that the LA report has inhibitory effects on various cell series of cancer. It has time dependent and dose -dependent cytotoxic effects, activating an anti -cancer mechanism by reducing the potential of mitochondrial membrane in specific cells. In some studies, LA at 30 and 50 µg/ml determined the EGFR (EGFR) receptor and reduced EGFR levels in lipid rafts in colon cancer models, leading to apoptosis. It is important to note that EGFR signaling plays a decisive role in the survival and evolution of cancer cells.

In a study of colon cancer cells, LA reduced glutathione levels and caused reactive oxygen species (ROS), leading to apostasy lesions and a cellular interruption. Another study noted the anti-proliferative and pre-transparent effects on endometrial and breast cancer cells. The lack of data on LA’s impact on Microorn’s expression remains, which prevents the further exploration of its anti -cancer effects and its mechanisms.

VCO and LA against the toxicity of chemotherapy

VCO contains bioactive natural compounds that fight the toxicity of chemotherapy, including ferulic acid, French acid, routine, caffeic acid and cbercetin. In a rat model, VCO was evaluated for the effects of inhibition of immunosuppression associated with doxoruvicin (DOX) chemotherapy. Specifically, the effect on CD4+ and CD8+ cells was studied. The DOX infusion suppressed the multiplication of lymphocytes, phagocytosis and macrophage capacity. Neurotoxicity indicators improved and VCO also reduced the deox hepatic and heart damage by reducing enzyme levels and creatine-MB kinase in rats.

Compared to VCO (FPVCO), VCO (HPVCO) underwriting (FPVCO), showed a greater antioxidant potential in various in vitro antioxidant tests. A comparative study revealed that cisplatin (CP), a leading anti -cancer agent, caused nephrotoxicity, which was relieved by HPVCO or FPVCO. Specifically, nephrotoxicity is the main side effect of CP chemotherapy.

The findings were similar to those against cyclophosphamide (CYP) hepato toxicity, in which VCO administration for 20 days relieved lipid peroxidation, hematological changes, oxidative stress and hepathetic dysfunction. One study showed that completion VCO improved the quality of life among patients with breast cancer. However, human clinical indications for anti-cancer and anti-toxicity effects remain limited.

Taking into account the existing literature, the effect of LA on the instrument specific to the toxicity of chemotherapy is unknown. One study evaluated cancer of cancer, a significant adverse effect of chemotherapy characterized by weight loss and skeletal muscles. In a mouse model, combining glucose and LA, orally administered in a single animal study, improved myocardial damage from cancer.

Conclusions

This review has shown that VCO and LA have anti -cancer effects and increase the anti -cancer efficacy of standard chemotherapeutic factors. Current elements are mainly concerned with preclinical mechanisms and efficiency, with limited security ratings. Most findings come from cell and animal studies, with sparse human data.

Future studies should be followed by structured safety protocols for food -related nanomnials. These evaluations will ensure the safe application of VCO/LA -based nanomorphosis on functional foods and treatments.

Download your PDF copy now!